Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Colesevelam Oral Suspension as Monotherapy or Add-on to Metformin Therapy in Pediatric Subjects With Type 2 Diabetes Mellitus

NCT01258075 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT01258075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01258075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Colesevelam Oral Suspension as Monotherapy or Add-on to Metformin Therapy in Pediatric Subjects With Type 2 Diabetes Mellitus
Lead sponsor
Daiichi Sankyo
Phase
Phase 4
Overall status
Completed
Start date
February 24, 2011
Completion date
April 21, 2020
Enrollment
236 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus